Article Versions Notes

Panagiotaki KN, Sideratou Z, Vlahopoulos SA, Paravatou-Petsotas M, Zachariadis M, Khoury N, Zoumpourlis V, Tsiourvas D. A Triphenylphosphonium-Functionalized Mitochondriotropic Nanocarrier for Efficient Co-Delivery of Doxorubicin and Chloroquine and Enhanced Antineoplastic Activity. Pharmaceuticals. 2017; 10(4):91. https://doi.org/10.3390/ph10040091

Panagiotaki, Katerina N., Zili Sideratou, Spiros A. Vlahopoulos, Maria Paravatou-Petsotas, Michael Zachariadis, Nikolas Khoury, Vassilis Zoumpourlis, and Dimitris Tsiourvas. 2017. "A Triphenylphosphonium-Functionalized Mitochondriotropic Nanocarrier for Efficient Co-Delivery of Doxorubicin and Chloroquine and Enhanced Antineoplastic Activity" Pharmaceuticals 10, no. 4: 91. https://doi.org/10.3390/ph10040091

Panagiotaki, K. N., Sideratou, Z., Vlahopoulos, S. A., Paravatou-Petsotas, M., Zachariadis, M., Khoury, N., Zoumpourlis, V., & Tsiourvas, D. (2017). A Triphenylphosphonium-Functionalized Mitochondriotropic Nanocarrier for Efficient Co-Delivery of Doxorubicin and Chloroquine and Enhanced Antineoplastic Activity. Pharmaceuticals, 10(4), 91. https://doi.org/10.3390/ph10040091